ArticleScientific reports2017

miR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-Met.

Xiaonian Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.